Hantz Financial Services Inc. Raises Stock Holdings in Tenet Healthcare Corporation $THC

Hantz Financial Services Inc. boosted its holdings in Tenet Healthcare Corporation (NYSE:THC) by 44.0% in the second quarter, HoldingsChannel reports. The firm owned 2,106 shares of the company’s stock after purchasing an additional 644 shares during the period. Hantz Financial Services Inc.’s holdings in Tenet Healthcare were worth $371,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Price T Rowe Associates Inc. MD boosted its holdings in Tenet Healthcare by 6.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 7,596,544 shares of the company’s stock valued at $1,021,736,000 after purchasing an additional 463,552 shares during the last quarter. Ameriprise Financial Inc. lifted its holdings in Tenet Healthcare by 348.4% during the 1st quarter. Ameriprise Financial Inc. now owns 1,962,314 shares of the company’s stock worth $263,905,000 after buying an additional 1,524,642 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in Tenet Healthcare by 12.2% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,675,199 shares of the company’s stock worth $225,297,000 after buying an additional 181,667 shares during the last quarter. Nuveen LLC bought a new position in Tenet Healthcare during the 1st quarter worth approximately $218,549,000. Finally, Boston Partners lifted its holdings in Tenet Healthcare by 692.9% during the 1st quarter. Boston Partners now owns 1,162,642 shares of the company’s stock worth $156,318,000 after buying an additional 1,016,010 shares during the last quarter. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Stock Down 1.0%

THC opened at $206.53 on Monday. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $217.43. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.63. The stock has a market cap of $18.25 billion, a P/E ratio of 14.16, a P/E/G ratio of 0.89 and a beta of 1.52. The stock’s 50 day moving average price is $195.84 and its 200 day moving average price is $173.45.

Tenet Healthcare (NYSE:THC) last posted its earnings results on Tuesday, October 28th. The company reported $3.70 EPS for the quarter, beating the consensus estimate of $3.33 by $0.37. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.The firm had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same period last year, the firm earned $2.93 EPS. The firm’s revenue was up 3.2% compared to the same quarter last year. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. As a group, research analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have commented on THC shares. Wall Street Zen raised Tenet Healthcare from a “hold” rating to a “strong-buy” rating in a report on Saturday, July 26th. JPMorgan Chase & Co. increased their target price on Tenet Healthcare from $190.00 to $200.00 and gave the stock an “overweight” rating in a report on Monday, August 4th. Cantor Fitzgerald increased their price target on Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. KeyCorp increased their price target on Tenet Healthcare from $205.00 to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Finally, Barclays increased their price target on Tenet Healthcare from $208.00 to $229.00 and gave the stock an “overweight” rating in a research report on Thursday, September 18th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $225.31.

Insiders Place Their Bets

In related news, CEO Saumya Sutaria sold 78,762 shares of the firm’s stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $190.78, for a total value of $15,026,214.36. Following the sale, the chief executive officer directly owned 368,683 shares in the company, valued at $70,337,342.74. This trade represents a 17.60% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard W. Fisher sold 2,500 shares of the stock in a transaction on Wednesday, October 29th. The shares were sold at an average price of $208.43, for a total value of $521,075.00. Following the transaction, the director directly owned 8,792 shares of the company’s stock, valued at approximately $1,832,516.56. The trade was a 22.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 93,222 shares of company stock valued at $17,682,090 in the last quarter. 0.81% of the stock is owned by insiders.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.